방사선치료계획 정도관리 방법에 따른 신뢰도 평가

다국어 초록 (Multilingual Abstract)

According as radiation therapy technique develops, standardization of radiation therapy has been complicated by the plan QA(Quality Assurance). However, plan QA tools are two type, OADT (opposite accumulation dose tool) and 3DADT (3 dimensional accumulation dose tool). OADT is not applied to evaluation of beam path. Therefore tolerance error of beam path will establish measurement value at OADT. Plan is six beam path, five irradiation field at each beam path. And beam path error is 0 degree, 0.2 degree, 0.4 degree, 0.6 degree, 0.6 degree, 0.8 degree. Plan QA accomplishes at OADT, 3DADT. The more path error increases, the more plan QA error increases. Tolerance error of OADT path is 0.357 using tolerance error of conventional plan QA. Henceforth plan QA using OADT will include beam path error. In addition, It will increase reliability through precise and various plan technique.

목차 (Table of Contents)

• Abstract
• 1. 서론
• 2. 대상 및 방법
• 2.1 대상
• 2.2 방법
• 3. 결과
• 3.1 대향형 정도관리 평가
• 3.2 3차원 정도관리 평가
• 3.3 허용오차의 설정
• 4. 결론 및 고찰
• 5. References

참고문헌 (Reference)

1 주상규, "필름을 사용한 세기변조치료법에 대한 선량측정" 대한방사선종양학회 20 (20): 11-178, 2002

2 홍채선, "세기조절방사선치료의 환자별 정도관리를 위한 2차원적 선량계의 유용성 평가" 대한방사선종양학회 27 (27): 91-102, 2009

3 윤상민, "세기조절방사선치료(IMRT) 환자의 QA" 대한방사선종양학회 20 (20): 10-90, 2002

4 A. Van Esch, "The use of an aSi-based EPID for routine absolute dosimetric pre-treatment verification of dynamic IMRT fields" 223-234, 2004

5 A. S. Garden, "Target coverage for head and neck cancers treated with IMRT: review of clinical experiences" 103-109, 2004

6 Vienna, "Physics: A Handbook for Teachers and Students" International Atomic Energy Agency 335-370, 2003

7 P. Fenoglietto, "Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk" 77-87, 2008

8 N. Agazaryan, "Patient specific quality assurance for the delivery of intensity modulated radiotherapy" 40-50, 2003

9 G. Yan, "On the sensitivity of patient-specific IMRT QA to MLC positioning errors" 2915-, 2009

10 M. Yao, "Health-related quality-of-life outcomes following IMRT versus conventional radiotherapy for oropharyngeal squamous cell carcinoma" 1354-1360, 2007

11 P. B. Greer, "Dosimetric properties of an amorphous silicon electronic portal imaging device for verification of dynamic intensity modulated radiation therapy" 1618-1627, 2003

12 J. Herzen, "Dosimetric evaluation of a 2D pixel ionization chamber for implementation in clinical routine" 1197-1208, 2007

13 L. Fenkell, "Dosimetric comparison of IMRT vs. 3D conformal radiotherapy in the treatment of cancer of the cervical esophagus" 287-291, 2008

14 "Comprehensive QA for Radiation Oncology" American Association of Physicists in Medicine 4197-4212, 2006

15 L. N. McDermott, "Clinical experience with EPID dosimetry for prostate IMRT pre-treatment dose verification" 3921-3930, 2006

16 C. Lee, "A simple approach to using an amorphous silicon EPID to verify IMRT planar dose maps" 984-992, 2009

17 M. C. Garofalo, "A comparison of 3D-CRT and IMRT planning for patients with T3Nx or T4Nx Mid/Distal rectal cancers: potential for small bowel sparing and reductions in Doselimiting acute GI toxicity" 250-, 2008